| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $225K | -28.8% |
| Cost of Revenue | $742K | -6.0% |
| R&D Expense | $10.2M | +13.7% |
| SG&A Expense | $6.8M | -6.2% |
| Operating Income | -$19.3M | -4.8% |
| Net Income | -$20.8M | +30.5% |
| EPS (Basic) | -$1.49 | +37.4% |
| EPS (Diluted) | -$1.49 | +37.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $38K | -45.7% |
| Inventory | $1.7M | +21.7% |
| Current Assets | $9.4M | +37.5% |
| Total Assets | $11.5M | +51.0% |
| Current Liabilities | $7.5M | +13.6% |
| Total Liabilities | $30.4M | +223.1% |
| Stockholders' Equity | -$18.8M | -969.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | -1.7% |
| Capital Expenditures | $980K | +540.5% |
| Investing Cash Flow | -$980K | -540.5% |
| Financing Cash Flow | $20.2M | -7.5% |
| Free Cash Flow | -$18.9M | -6.3% |